Leveraging Behavioral Economics to Understand and Improve Financial Decision Making Among Vulnerable Older Adults

July 2, 2026 updated by: Abdelaziz Alsharawy, The University of Texas Health Science Center, Houston
This study seeks to test novel informational content / nudge strategies to mitigate financial vulnerability among older adults.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • The University of Texas Health Science Center at Houston

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adults over the age of 60
  • English speakers, to ensure comprehension of study tasks
  • High vulnerability to financial exploitation as assessed by the Financial Exploitation Vulnerability Scale (FEVS)

Exclusion Criteria:

  • Less than age 60
  • Non-English speaker

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Participants receiving informational self-nudges to improve financial decision-making
Participants will be asked to virtually go through financial self-nudging informational content during the week prior to completing behavioral tasks. Self-nudging informational content contains strategies to enhance financial decision-making.
Participants will be asked to virtually go through financial self-nudging informational content during the week prior to completing behavioral tasks. Self-nudging informational content contains strategies to enhance financial decision-making.
Experimental: Control - Participants receiving informational content on healthy eating and physical activity
The control group will be exposed to informational content on healthy eating and physical activity (obtained through the U.S. Centers for Disease Control and Prevention and/or National Institute on Aging webpages).
The control group will be exposed to informational content on healthy eating and physical activity (obtained through the U.S. Centers for Disease Control and Prevention and/or National Institute on Aging webpages).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of choosing the riskier option on the risk tolerance decision-making task
Time Frame: During the time of the decision-making task (about 5-10 minutes)
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards. The study team will administer the following decision-making task via a web-based survey platform to characterize risk tolerance (willingness to accept uncertain outcomes). The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
During the time of the decision-making task (about 5-10 minutes)
Frequency of choosing the more trusting option on the trust decision-making task
Time Frame: During the time of the decision-making task (about 5-10 minutes)
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards. The study team will administer the following decision-making task via a web-based survey platform to characterize interpersonal trust (willingness to accept being vulnerable to other people). The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
During the time of the decision-making task (about 5-10 minutes)
Frequency of choosing the more altruistic option on the altruism decision-making task
Time Frame: During the time of the decision-making task (about 5-10 minutes)
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards. The study team will administer the following decision-making task via a web-based survey platform to characterize altruism (willingness to incur a financial cost to benefit another person). The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
During the time of the decision-making task (about 5-10 minutes)
Frequency of choosing the more patient option on the impatience decision-making task
Time Frame: During the time of the decision-making task (about 5-10 minutes)
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards. The study team will administer the following decision-making task via a web-based survey platform to characterize patience (willingness to forego a sooner reward for a bigger future reward). The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
During the time of the decision-making task (about 5-10 minutes)
Frequency of choosing the less loss-averse option on the loss-aversion decision-making task
Time Frame: During the time of the decision-making task (about 5-10 minutes)
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards. The study team will administer the following decision-making task via a web-based survey platform to characterize loss aversion (tendency to weigh potential losses more heavily than equivalent gains). The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
During the time of the decision-making task (about 5-10 minutes)
Physiological arousal as measured via heart rate
Time Frame: During the time of the decision-making tasks (about 20-40 minutes)
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
During the time of the decision-making tasks (about 20-40 minutes)
Physiological arousal as measured via skin conductance
Time Frame: During the time of the decision-making tasks (about 20-40 minutes)
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
During the time of the decision-making tasks (about 20-40 minutes)
Physiological arousal as measured via pupil dilation
Time Frame: During the time of the decision-making tasks (about 20-40 minutes)
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
During the time of the decision-making tasks (about 20-40 minutes)
Frequency of facial expressions associated with valence and engagement
Time Frame: During the time of the decision-making tasks (about 20-40 minutes)
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks. Facial expressions will be assessed using a facial expression analysis system (iMotions software).
During the time of the decision-making tasks (about 20-40 minutes)
Attention as assessed by eye fixations
Time Frame: During the time of the decision-making tasks (about 20-40 minutes)
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks. Relative fixation duration on each option in the behavioral tasks will be measured via an eye tracker (SmartEye).
During the time of the decision-making tasks (about 20-40 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Response time during the behavioral tasks
Time Frame: During the time of the decision-making tasks (about 20-40 minutes)
Response time will be reported as the time from stimulus presentation to choice, in milliseconds.
During the time of the decision-making tasks (about 20-40 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Abdelaziz Alsharawy, PhD, The University of Texas Health Science Center, Houston

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2027

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

June 26, 2026

First Submitted That Met QC Criteria

June 26, 2026

First Posted (Actual)

July 6, 2026

Study Record Updates

Last Update Posted (Actual)

July 7, 2026

Last Update Submitted That Met QC Criteria

July 2, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • HSC-SPH-25-0344 (Trial)
  • P30AG086563 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Financial Exploitation of Older Adults

3
Subscribe